Home LiteratureArticle Details
PMID: 16415178 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (taxotere).

Molecular pharmacology ·Vol. 69 ·No. 4 ·2006-04-00 ·Pages 1207-15

Lu H, Murtagh J, Schwartz EL

Abstract

Laulimalide, a natural product from marine sponges, is a microtubule-stabilizing agent that binds to tubulin at a site distinct from that of the taxoids. In the present study, we found that laulimalide inhibited human umbilical vein endothelial cell (HUVEC) tubule formation and vascular endothelial growth factor (VEGF)-induced HUVEC migration, key components of the angiogenic process. These occurred at concentrations substantially lower than that which inhibited HUVEC proliferation. When combined, laulimalide and docetaxel (Taxotere) synergistically inhibited migration and tubule formation, but their combined effect on proliferation was antagonistic. Possible mechanism(s) by which laulimalide inhibited VEGF-induced HUVEC migration were explored. Similar to docetaxel, laulimalide had no effect on the VEGF-induced tyrosine phosphorylation of the VEGF receptor Flk-1/KDR (VEGFR-2). Low concentrations of laulimalide substantially blocked subsequent VEGFR-2 downstream events, as did docetaxel, including the phosphorylation of the Tyr397 and Tyr407 residues of focal adhesion kinase (FAK), the association of VEGFR-2 with FAK and Hsp90, and the Tyr31 phosphorylation of paxillin. Laulimalide inhibited integrin activation; however, compared with docetaxel, it had a weaker inhibitory effect on the VEGF-induced association of VEGFR-2 with the alpha5beta1 integrin. Compared with docetaxel, laulimalide more potently caused a reduction in the constitutive levels (i.e., in the absence of VEGF) of phosphorylated paxillin and more potently inhibited the association of RhoA with the alpha5beta1 integrin. In conclusion, although both docetaxel and laulimalide inhibited integrin-associated signaling pathways that mediated VEGF-induced cell migration, their actions on the signaling cascade seemed not to be identical. These complementary actions could account for their synergistic effects on HUVEC.

MeSH Terms
Cell Movement/drug effects Cell Proliferation/drug effects Cells, Cultured Docetaxel Drug Synergism Endothelial Growth Factors/pharmacology Endothelium, Vascular/cytology,drug effects Focal Adhesion Protein-Tyrosine Kinases/antagonists & inhibitors,metabolism Humans Integrin alphaVbeta3/metabolism Macrolides Microtubules/drug effects Paxillin/antagonists & inhibitors,metabolism Phosphorylation Taxoids/pharmacology Vascular Endothelial Growth Factor Receptor-2/metabolism
Chemicals
Endothelial Growth Factors Integrin alphaVbeta3 Macrolides Paxillin Taxoids laulimalide Docetaxel Vascular Endothelial Growth Factor Receptor-2 Focal Adhesion Protein-Tyrosine Kinases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lu Haiyan
Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA.
Murtagh Janice
Schwartz Edward L
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
2006-04-00
Epub
2006-00-13
Pages
1207-15
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Grants
NCI NIH HHS · R01 CA098456 · United States
NCI NIH HHS · CA98456 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com